(Q46871110)

26 December 2017

title

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial (English)

1 reference

26 December 2017

main subject

prevention of HIV/AIDS

0 references

0 references

1 reference

2

Gita Ramjee

1 reference

26 December 2017

author name string

Stephanie Skoler-Karpoff

1

1 reference

26 December 2017

Khatija Ahmed

3

1 reference

26 December 2017

Lydia Altini

4

1 reference

26 December 2017

Marlena Gehret Plagianos

5

1 reference

26 December 2017

Barbara Friedland

6

1 reference

26 December 2017

Sumen Govender

7

1 reference

26 December 2017

Alana De Kock

8

1 reference

26 December 2017

Nazira Cassim

9

1 reference

26 December 2017

Thesla Palanee

10

1 reference

26 December 2017

Gregory Dozier

11

1 reference

26 December 2017

Robin Maguire

12

1 reference

26 December 2017

Pekka Lahteenmaki

13

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

26 December 2017

published in

The Lancet

1 reference

26 December 2017

volume

372

1 reference

26 December 2017

issue

9654

1 reference

26 December 2017

page(s)

1977-1987

1 reference

26 December 2017

Update on male circumcision: prevention success and challenges ahead

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

SAVVY® (C31G) Gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Carrageenan/MIV-150 (PC-815), a combination microbicide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Carrageenan-based nonoxynol-9 spermicides for prevention of sexually transmitted infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Relative safety of sexual lubricants for rectal intercourse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Carraguard Vaginal Gel Safety in HIV-Positive Women and Men in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Acceptability and feasibility of Micralax applicators and of methyl cellulose gel placebo for large-scale clinical trials of vaginal microbicides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Assay for establishing whether microbicide applicators have been exposed to the vagina.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Will microbicide trials yield unbiased estimates of microbicide efficacy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Recommendations for the clinical development of topical microbicides: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Vaginal microbicides: moving ahead after an unexpected setback.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Perceptions of anal sex in rural South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Screening for genital and anorectal sexually transmitted infections in HIV prevention trials in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

Need for a true placebo for vaginal microbicide efficacy trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961842-5

7 January 2021

10.1016/S0140-6736(08)61842-5

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017